Drugmaker Vivus Inc said Chief Executive Anthony Zook resigned for health reasons, barely a month and a half after he assumed the role
Vivus's board on Tuesday named Seth H.Z. Fischer, a former senior executive at Johnson & Johnson, the new CEO. Fischer will also join the Vivus board.
Vivus had faced intense investor criticism for the launch of its diet pill Qsymia, leading to an investor revolt that ended with the revamp of the company's board and the appointment of Zook as CEO. Read more.